Advertisement
Ribociclib plus letrozole is associated with significantly longer progression-free survival for patients receiving initial systemic treatment for hormone receptor-positive

Ribociclib + Letrozole Beneficial in Advanced Breast Cancer

0
Longer duration of progression-free survival in patients with HR+, HER2− breast cancer
Many men who have sex with men are not aware that pre-exposure prophylaxis medication can protect them from HIV

Not Enough Men Who Have Sex With Men Aware of PrEP

0
Only 42 percent of Baltimore MSM knew about pre-exposure prophylaxis medication
Even partial steroid treatment before birth can improve survival odds for extremely premature infants and reduce their risk of certain birth defects

Even Partial Antenatal Steroid Treatment Benefits Preemies

0
Fewer deaths, complications for extremely premature infants
For adults with sepsis

Levosimendan Doesn’t Prevent Acute Organ Dysfunction

0
Drug also tied to lower odds of successful weaning from mechanical ventilation in adults with sepsis
Treatment with tamoxifen or aromatase inhibitors does cut breast cancer patients' risk of developing cancer in their other breast

Long-Term Tamoxifen Does Lower Contralateral Breast Cancer Risk

0
Six-year study finds follow-up therapy cuts survivors' risk for cancer in the other breast
Adding daratumumab to standard treatment for advanced cases of multiple myeloma may significantly improve patients' chances of a response and even recovery

Adding Daratumumab to Standard Tx Effective in Multiple Myeloma

0
43.1 percent of study patients had a complete response
After adjusting for inflation

Price Increases Larger for Older Cancer Drugs Than Newer Ones

0
Older meds rose 22.7 percent in price, compared to a 6.2 percent increase for newer treatments
The United States lags behind other advanced nations when it comes to infant mortality and the life expectancy of its citizens

Global Burden of Disease Report Evaluates the World’s Health

0
Life expectancy in the United States trails other wealthy nations
An experimental drug -- a vasopressin antagonist called ABT-436 -- shows some promise in treating alcohol use disorder and smoking

New Drug for Alcohol Use Disorder Appears Promising

0
Smokers may also benefit, results of a clinical trial suggest
Electronic-cigarette devices are randomly and unexpectedly exploding

Burns, Blast Injuries on the Rise From Exploding E-Cigarettes

0
Users say they're unaware the lithium batteries are a potential fire hazard